Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
Q1 2026 earnings • released • EPS beat +219.15% • Revenue beat +2.72%
See results
TXG:NASDAQ
10X Genomics Inc
$21.60
-3.66%
(-0.82) 1D
$21.67
+0.32% (+0.070)
After hours
Closed: May 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXG...
Open
$21.07
High
$21.99
Low
$19.82
Mkt. cap
2.79B
Avg. vol.
2.45M
Volume
4.83M
52-wk high
$26.44
52-wk low
$8.06
EPS
-$0.17
Beta
2.05
Shares outstanding
118.91M
No. of employees
1K
News stories
From sources across the web
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOSerge Saxonov
Employees1.18K
Founded2012
HeadquartersPleasanton, California, United States
SectorHealth care
Website10xgenomics.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.07 / -$0.06
+219.15%beat
Revenue / Est. (USD)
150.84M / 146.85M
+2.72%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
172.91M
149.00M
166.03M
150.84M
Cost of goods sold
47.42M
48.70M
52.88M
44.66M
Cost of revenue
47.42M
48.70M
52.88M
-
Research and development expenses
57.32M
57.19M
55.77M
56.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.71M
74.66M
73.02M
-
Operating expense
130.04M
131.85M
128.79M
123.22M
Total operating expenses
177.46M
180.54M
181.67M
-
Operating income
-4.55M
-31.54M
-15.64M
-17.05M
Other non operating income
2.60M
538.00K
-3.04M
-815.00K
EBT including unusual items
37.00M
-28.20M
-15.19M
-12.85M
EBT excluding unusual items
2.32M
-26.40M
-12.39M
-12.85M
Income tax expense
2.46M
-733.00K
1.06M
623.00K
Effective tax rate
6.65%
2.60%
-6.97%
-4.85%
Other operating expenses
-
-
-
-
Net income
34.54M
-27.47M
-16.25M
-13.47M
Net profit margin
19.97%
-18.44%
-9.79%
-
Earnings per share
0.48
-0.02
0.07
0.07
Interest and investment income
4.27M
5.20M
6.89M
5.01M
Interest expense
-3.00K
-
-
-
Net interest expenses
4.27M
5.20M
6.89M
5.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.26M
-21.24M
-5.58M
-8.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer